Related Experiment Video
Updated: Aug 9, 2025

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Liquid Crystal Monomer: A Potential PPARγ Antagonist.
Haoduo Zhao1,2, Caixia Li2, Mihir Yogesh Naik3
1School of Civil and Environmental Engineering, Nanyang Technological University, 639798 Singapore.
Liquid crystal monomers (LCMs) can harm health by blocking PPARγ. This study reveals their toxic effects and mechanisms, aiding future chemical risk assessments.
Area of Science:
- Environmental chemistry
- Toxicology
- Biochemistry
Background:
- Liquid crystal monomers (LCMs) are prevalent in LCDs and e-waste.
- Research on LCM environmental presence is growing, but toxic effects are understudied.
Purpose of the Study:
- To comprehensively elucidate the toxicity and mechanisms of LCMs using integrated omics analysis.
- To identify specific molecular targets and pathways affected by LCM exposure.
Main Methods:
- Utilized in silico simulation, in vitro assays, and omics integration (metabolome, transcriptome).
- Employed high-throughput virtual screening and reporter gene assays.
- Analyzed LCM effects on HK2 cells.
Main Results:
- Identified specific LCMs antagonizing peroxisome proliferator-activated receptor gamma (PPARγ).
- Observed global metabolome and transcriptome dysregulation in HK2 cells.
- Found significant dysregulation of fatty acid β-oxidation, potentially mediated by IL-17, TNF, and NF-kB pathways.
Conclusions:
- LCMs act as potential PPARγ antagonists.
- Discovered a trans-omics toxicological mode of action for LCMs.
- Findings offer insights for future chemical risk assessments of LCMs.
More Related Videos
10:51Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
07:13Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
Published on: May 24, 2024